These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11983875)

  • 1. Unraveling the genetics and mechanisms of cardiac arrhythmia.
    Noble D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5755-6. PubMed ID: 11983875
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrinsic cardiac neurons express cardiac-type sodium channels implicated in arrhythmias.
    Hoover DB
    Heart Rhythm; 2006 Jul; 3(7):851-2. PubMed ID: 16818220
    [No Abstract]   [Full Text] [Related]  

  • 3. Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds.
    Lopez KN; Decker JA; Friedman RA; Kim JJ
    Heart Rhythm; 2011 Mar; 8(3):471-3. PubMed ID: 20950709
    [No Abstract]   [Full Text] [Related]  

  • 4. The heart on a chip: the role of realistic mathematical models of cardiac electrical activity in understanding and treating cardiac arrhythmias.
    Nattel S
    Heart Rhythm; 2007 Jun; 4(6):779-80. PubMed ID: 17556202
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium channel (dys)function and cardiac arrhythmias.
    Remme CA; Bezzina CR
    Cardiovasc Ther; 2010 Oct; 28(5):287-94. PubMed ID: 20645984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics. Gene mutation may boost risk of heart arrhythmias.
    Marx J
    Science; 2002 Aug; 297(5585):1252. PubMed ID: 12193756
    [No Abstract]   [Full Text] [Related]  

  • 7. Arrhythmias and dilated cardiomyopathy common pathogenetic pathways?
    Towbin JA; Lorts A
    J Am Coll Cardiol; 2011 May; 57(21):2169-71. PubMed ID: 21596232
    [No Abstract]   [Full Text] [Related]  

  • 8. Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats.
    Korkmaz S; Zitron E; Bangert A; Seyler C; Li S; Hegedüs P; Scherer D; Li J; Fink T; Schweizer PA; Giannitsis E; Karck M; Szabó G; Katus HA; Kaya Z
    J Am Coll Cardiol; 2013 Jul; 62(4):340-9. PubMed ID: 23684688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin43 and Na(V)1.5: partners in crime?
    Remme CA
    Heart Rhythm; 2012 Apr; 9(4):608-9. PubMed ID: 22182494
    [No Abstract]   [Full Text] [Related]  

  • 10. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From GWAS to function: genetic variation in sodium channel gene enhancer influences electrical patterning.
    van den Boogaard M; Barnett P; Christoffels VM
    Trends Cardiovasc Med; 2014 Apr; 24(3):99-104. PubMed ID: 24360055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmia mutations in non-coding region of SCN5A: implications for genetic screening.
    Makielski JC; Valdivia CR
    J Mol Cell Cardiol; 2005 Apr; 38(4):551-3. PubMed ID: 15808831
    [No Abstract]   [Full Text] [Related]  

  • 13. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
    Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
    Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
    Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second case with arrhythmogenic cardiomyopathy, provocable Brugada ECG and SCN5A mutation.
    S P
    Int J Cardiol; 2014 Feb; 171(3):e117-8. PubMed ID: 24388542
    [No Abstract]   [Full Text] [Related]  

  • 16. Brugada syndrome: 12 years of progression.
    Hong K; Antzelevitch C; Brugada P; Brugada J; Ohe T; Brugada R
    Acta Med Okayama; 2004 Dec; 58(6):255-61. PubMed ID: 15762293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the influence of genomic context on pleiotropy in SCN5A-mediated cardiac channelopathies: Insights from the Worm Study.
    Giudicessi JR
    Heart Rhythm; 2023 May; 20(5):728-729. PubMed ID: 36858161
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton modulation of cardiac I Na: a potential arrhythmogenic trigger.
    Jones DK; Ruben PC
    Handb Exp Pharmacol; 2014; 221():169-81. PubMed ID: 24737236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the Clinical Validity of Arrhythmia-Related Genetic Variations Using the Electronic Medical Record: A Valid Take on Precision Medicine?
    Feero WG
    JAMA; 2016 Jan; 315(1):33-5. PubMed ID: 26746455
    [No Abstract]   [Full Text] [Related]  

  • 20. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.
    Papadatos GA; Wallerstein PM; Head CE; Ratcliff R; Brady PA; Benndorf K; Saumarez RC; Trezise AE; Huang CL; Vandenberg JI; Colledge WH; Grace AA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6210-5. PubMed ID: 11972032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.